On November 9, ISDA sent a paper to the European Commission and UK Financial Conduct Authority recommending that over-the-counter (OTC) derivatives are identified using unique product identifiers (UPIs) for EU and UK transparency requirements, augmented with some key trade-level attributes (known as UPI+). ISDA believes this would be more appropriate than ISINs because it would enable users to aggregate and perform meaningful analysis on instrument pricing across the market. These additional attributes would ensure OTC derivatives could be identified and aggregated in a way that is useful to market participants while providing sufficient granularity to distinguish between different products.
Documents (1) for ISDA Paper on Unique Product Identifiers
Latest
Market Transformation – IQ May 2026
On the 250th anniversary of American independence, this year’s ISDA Annual General Meeting (AGM) was held in Boston, a city that played a prominent role in the American Revolution. In his opening remarks, ISDA chief executive Scott O’Malia drew a...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
Letter to EC and ESMA on Derivatives Framework
On March 27, ISDA sent a letter to the European Commission (EC) and the European Securities and Markets Authority (ESMA) to highlight several technical issues arising from the interaction between the delegated regulation (EU) 2025/1003 on identifying reference data to...
Response on Proposed Changes to Transaction Rules
On May 22, ISDA and the Global Foreign Exchange Division (GFXD) of the Global Financial Markets Association submitted a joint response to the Australian Securities and Investments Commission's (ASIC) consultation on proposed changes to the ASIC Derivative Transaction Rules (Reporting)...